Safety and immunogenicity of H5N1 vaccine

被引：3
|
作者：
Authier, F. J. [1 ]
Gherardi, R. K. [1 ]
机构：
[1] Univ Paris 12, Fac Med, Henri Mondor Hosp,AP HP, INSERM,E0011,Reference Ctr Neuromuscular Disorder, F-94000 Creteil, France
来源：
LANCET | 2006年 / 368卷 / 9554期
关键词：
D O I：
10.1016/S0140-6736(06)69891-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2209 / 2210
页数：2
相关论文
共 50 条
  • [1] Safety and Immunogenicity of a Prepandemic Influenza A (H5N1) Vaccine in Children
    Vajo, Zoltan
    Kosa, Lajos
    Szilvasy, Istvan
    Pauliny, Zsuzsanna
    Bartha, Kalman
    Visontay, Ildiko
    Kis, Agnes
    Tarjan, Ildiko
    Rozsa, Noemi
    Jankovics, Istvan
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (12) : 1052 - 1056
  • [2] Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
    Treanor, JJ
    Campbell, JD
    Zangwill, KM
    Rowe, T
    Wolff, M
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (13): : 1343 - 1351
  • [3] Safety and Immunogenicity of Multiple and Higher Doses of an Inactivated Influenza A/H5N1 Vaccine
    Beigel, John H.
    Voell, Jocelyn
    Huang, Chiung-yu
    Burbelo, Peter D.
    Lane, H. Clifford
    JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (04): : 501 - 509
  • [4] Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults
    Bernstein, David I.
    Edwards, Kathryn M.
    Dekker, Cornelia L.
    Belshe, Robert
    Talbot, Helen K. B.
    Graham, Irene L.
    Noah, Diana L.
    He, Fenhua
    Hill, Heather
    JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (05): : 667 - 675
  • [5] Immunogenicity and safety of an AS03A-adjuvanted H5N1 influenza vaccine in a Taiwanese population
    Hwang, Shinn-Jang
    Chang, Shan-Chwen
    Yu, Chong-Jen
    Chan, Yu-Jiun
    Chen, Tzeng-Ji
    Hsieh, Shie-Liang
    Lai, Hsiu-Yun
    Lin, Ming-Hsien
    Liu, Jui-Yao
    Ong, Gary
    Roman, Francois
    Drame, Mamadou
    Bock, Hans L.
    Yang, Pan-Chyr
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2011, 110 (12) : 780 - 786
  • [6] Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine
    Winokur, Patricia L.
    Patel, Shital M.
    Brady, Rebecca
    Chen, Wilbur H.
    El-Kamary, Samer S.
    Edwards, Kathryn
    Creech, C. Buddy
    Frey, Sharon
    Keitel, Wendy A.
    Belshe, Robert
    Walter, Emmanuel
    Bellamy, Abbie
    Hill, Heather
    JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (04): : 525 - 530
  • [7] Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1
    Nicolodi, Christina
    Groiss, Franz
    Kiselev, Oleg
    Wolschek, Markus
    Seipelt, Joachim
    Muster, Thomas
    VACCINE, 2019, 37 (28) : 3722 - 3729
  • [8] Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine From Infancy to Adolescence
    Vesikari, Timo
    Karvonen, Aino
    Tilman, Sandrine
    Borkowski, Astrid
    Montomoli, Emanuele
    Banzhoff, Angelika
    Clemens, Ralf
    PEDIATRICS, 2010, 126 (04) : E762 - E770
  • [9] Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans
    Zangwill, Kenneth M.
    Treanor, John J.
    Campbell, James D.
    Noah, Diana L.
    Ryea, Jennifer
    JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (04): : 580 - 583
  • [10] Safety and Immunogenicity of H5N1 Influenza Vaccine Based on Baculovirus Surface Display System of Bombyx mori
    Jin, Rongzhong
    Lv, Zhengbing
    Chen, Qin
    Quan, Yanping
    Zhang, Haihua
    Li, Si
    Chen, Guogang
    Zheng, Qingliang
    Jin, Lairong
    Wu, Xiangfu
    Chen, Jianguo
    Zhang, Yaozhou
    PLOS ONE, 2008, 3 (12):
12345